Ampicillin/Cloxacillin Sodium

氨苄西林/氯唑西林钠

Report date: 2022/01/14 13:23:58

Base Information

Drug NameAmpicillin/Cloxacillin Sodium
Drug Alias NameViccillin-S
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionBacterial penicillin-binding protein inhibitors
TargetsBacterial penicillin-binding protein
Therapy Area/IndicationsEndocarditisMeningitisUrinary Tract Infections +[6] 
Global Approved IndicationsEndocarditisMeningitisUrinary Tract Infections +[6] 
Approved Indications in ChinaEndocarditisMeningitisUrinary Tract Infections +[6] 
Original Approved Country/TerritoryMainland China
Original Approved Date2012/08/16
Country/TerritoryMainland China
CombinationsYes Cloxacillin SodiumAmpicillin
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesMeiji Seika Pharma
China Registration ClassN/A

Develop Information

Active CompaniesBright Future Pharmaceuticals Factory
Inactive CompaniesN/A
Active IndicationsEndocarditisMeningitisUrinary Tract Infections +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeJ01CA51
Related LinksN/A